Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Video

Updated: May 15, 2026

Clinical Microfluidic Chip Platform for the Isolation of Versatile Circulating Tumor Cells
05:58

Clinical Microfluidic Chip Platform for the Isolation of Versatile Circulating Tumor Cells

Published on: October 13, 2023

Probing circulating tumor cells in microfluidics.

Peng Li1, Zackary S Stratton, Ming Dao

  • 1Department of Engineering Science and Mechanics, The Pennsylvania State University, University Park, PA 16802, USA.

Lab on a Chip
|January 12, 2013
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Long-term stability of posttranscriptional genetic silencing of BCL11A using a shmiR vector in Sickle Cell Disease.

Blood·2026
Same author

Efficacy and safety of durcabtagene autoleucel in a phase 1 trial for patients with relapsed/refractory multiple myeloma.

Science translational medicine·2026
Same author

Isolation of small extracellular vesicles from small volumes of blood plasma using size exclusion chromatography and density gradient ultracentrifugation.

eLife·2026
Same author

An AI-enabled tool for quantifying overlapping red blood cell sickling dynamics in microfluidic assays.

Lab on a chip·2026
Same author

Randomized, Placebo-Controlled Trial of B-Cell Depletion for Prevention of Corticosteroid-Requiring Chronic Graft-Versus-Host Disease.

Journal of clinical oncology : official journal of the American Society of Clinical Oncology·2026
Same author

CD19 CAR T-Cell Therapy for Treatment of Chronic Graft-versus-Host Disease.

The New England journal of medicine·2026
Same journal

Microfluidic rare cell analysis beyond counting: workflow design from enrichment to multi-omics.

Lab on a chip·2026
Same journal

A sperm racetrack to separate sperm by swim speed.

Lab on a chip·2026
Same journal

Controlled encapsulation and droplet size prediction in two-step microfluidic double emulsions.

Lab on a chip·2026
Same journal

A particulate blood-mimicking fluid with physiological biconcave geometry for microscale hemorheology.

Lab on a chip·2026
Same journal

Multicellular sensor arrays fabricated by capillary stamping for pattern-based odor discrimination.

Lab on a chip·2026
Same journal

A real-time microfluidic surveillance system for multiplex detection of heavy metal contamination in wastewater.

Lab on a chip·2026
See all related articles

Microfluidic devices offer advanced methods for isolating and detecting circulating tumor cells (CTCs) in blood. Future research should focus on improving these microfluidic technologies for better cancer diagnostics and treatment strategies.

Area of Science:

  • Biomedical Engineering
  • Oncology
  • Nanotechnology

Background:

  • Circulating tumor cells (CTCs) are crucial biomarkers for cancer detection, prognosis, and treatment monitoring.
  • The extremely low concentration of CTCs in blood presents significant technical challenges for their isolation, enrichment, and characterization.
  • Current CTC detection methods often lack the sensitivity and specificity required for clinical applications.

Purpose of the Study:

  • To review recent advancements in microfluidic platforms for the separation and detection of circulating tumor cells (CTCs).
  • To provide an expert appraisal of the current state of microfluidic CTC technologies.
  • To identify future research directions and opportunities in the field of microfluidic CTC analysis.

Main Methods:

More Related Videos

Microfluidics-based High-throughput Circulating Tumor Cell Sorting and Single-cell Sequencing Technology
09:45

Microfluidics-based High-throughput Circulating Tumor Cell Sorting and Single-cell Sequencing Technology

Published on: November 14, 2025

A Method of Targeted Cell Isolation via Glass Surface Functionalization
10:40

A Method of Targeted Cell Isolation via Glass Surface Functionalization

Published on: September 20, 2016

Related Experiment Videos

Last Updated: May 15, 2026

Clinical Microfluidic Chip Platform for the Isolation of Versatile Circulating Tumor Cells
05:58

Clinical Microfluidic Chip Platform for the Isolation of Versatile Circulating Tumor Cells

Published on: October 13, 2023

Microfluidics-based High-throughput Circulating Tumor Cell Sorting and Single-cell Sequencing Technology
09:45

Microfluidics-based High-throughput Circulating Tumor Cell Sorting and Single-cell Sequencing Technology

Published on: November 14, 2025

A Method of Targeted Cell Isolation via Glass Surface Functionalization
10:40

A Method of Targeted Cell Isolation via Glass Surface Functionalization

Published on: September 20, 2016

  • Review of recent scientific literature on microfluidic devices for CTC separation and detection.
  • Analysis of the advantages and limitations of various microfluidic approaches.
  • Discussion of emerging trends and technological innovations in the field.
  • Main Results:

    • Microfluidic technologies have shown significant promise in improving the efficiency and accuracy of CTC isolation and detection.
    • Various microfluidic platforms exploit unique physical and biochemical properties of CTCs for enhanced separation.
    • Integration of microfluidic devices with advanced detection systems enables more comprehensive CTC characterization.

    Conclusions:

    • Microfluidic devices represent a powerful tool for advancing CTC research and clinical applications in oncology.
    • Continued innovation in microfluidic design and detection methodologies is essential for overcoming current challenges.
    • Future efforts should focus on standardization, clinical validation, and translation of microfluidic CTC technologies into routine diagnostics.